These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10534255)

  • 21. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study.
    Li G; Larson EB; Shofer JB; Crane PK; Gibbons LE; McCormick W; Bowen JD; Thompson ML
    J Am Geriatr Soc; 2017 Dec; 65(12):2627-2633. PubMed ID: 28940184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
    Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ
    Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of APOE and CD33 on Cognitive Decline.
    Hayden KM; Lutz MW; Kuchibhatla M; Germain C; Plassman BL
    PLoS One; 2015; 10(6):e0130419. PubMed ID: 26102276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein epsilon4 allele and problems with orientation are associated with a persistent decline in cognition in community-dwelling elderly persons.
    Wayne SJ; Vellas BJ; Brodie SG; Garry PJ; Baumgartner RN
    J Gerontol A Biol Sci Med Sci; 2005 Mar; 60(3):375-9. PubMed ID: 15860477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction.
    Yaffe K; Haan M; Byers A; Tangen C; Kuller L
    Neurology; 2000 May; 54(10):1949-54. PubMed ID: 10822435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Education modifies the effect of apolipoprotein epsilon 4 on cognitive decline.
    Shadlen MF; Larson EB; Wang L; Phelan EA; McCormick WC; Jolley L; Teri L; van Belle G
    Neurobiol Aging; 2005 Jan; 26(1):17-24. PubMed ID: 15585342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
    Klages J; Fisk JD
    Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein e4 allele and cognitive decline in elderly men.
    Feskens EJ; Havekes LM; Kalmijn S; de Knijff P; Launer LJ; Kromhout D
    BMJ; 1994 Nov; 309(6963):1202-6. PubMed ID: 7987151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4.
    Olofsson JK; Rönnlund M; Nordin S; Nyberg L; Nilsson LG; Larsson M
    Behav Genet; 2009 Sep; 39(5):496-503. PubMed ID: 19633944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOE ε4 allele modifies the association of lead exposure with age-related cognitive decline in older individuals.
    Prada D; Colicino E; Power MC; Weisskopf MG; Zhong J; Hou L; Spiro A; Vokonas P; Brenan K; Herrera LA; Schwartz J; Wright R; Hu H; Baccarelli AA
    Environ Res; 2016 Nov; 151():101-105. PubMed ID: 27474937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gender difference in the association between APOE genotype and age-related cognitive decline.
    Mortensen EL; Høgh P
    Neurology; 2001 Jul; 57(1):89-95. PubMed ID: 11445633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.
    Krell-Roesch J; Woodruff BK; Acosta JI; Locke DE; Hentz JG; Stonnington CM; Stokin GB; Nagle C; Michel BF; Sambuchi N; Caselli RJ; Geda YE
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):322-5. PubMed ID: 25803305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals.
    Olofsson JK; Larsson M; Roa C; Wilson DA; Jonsson Laukka E
    Behav Genet; 2020 Jan; 50(1):3-13. PubMed ID: 31760549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical activity and cognitive decline, the role of the apolipoprotein e4 allele.
    Schuit AJ; Feskens EJ; Launer LJ; Kromhout D
    Med Sci Sports Exerc; 2001 May; 33(5):772-7. PubMed ID: 11323547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
    Small BJ; Graves AB; McEvoy CL; Crawford FC; Mullan M; Mortimer JA
    Neurology; 2000 Jun; 54(11):2082-8. PubMed ID: 10851367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.